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Endogenous formaldehyde is producedbynumerous
biochemical pathways fundamental to life, and it
can crosslink both DNA and proteins. However, the
consequences of its accumulation are unclear. Here
we show that endogenous formaldehyde is removed
by the enzyme alcohol dehydrogenase 5 (ADH5/
GSNOR), and Adh5/ mice therefore accumulate
formaldehyde adducts in DNA. The repair of this
damage is mediated by FANCD2, a DNA crosslink
repair protein. Adh5/Fancd2/ mice reveal an
essential requirement for these protection mecha-
nisms in hematopoietic stem cells (HSCs), leading
to their depletion and precipitating bone marrow fail-
ure. More widespread formaldehyde-induced DNA
damage also causes karyomegaly and dysfunction
of hepatocytes and nephrons. Bone marrow trans-
plantation not only rescued hematopoiesis but,
surprisingly, also preservednephron function. Never-
theless, all of these animals eventually developed
fatal malignancies. Formaldehyde is therefore an
important source of endogenous DNA damage that
is counteracted in mammals by a conserved protec-
tion mechanism.
INTRODUCTION
Chromosomal DNA is intrinsically unstable. The nuclear environ-
ment leads to spontaneous base decomposition through pro-
cesses such as deamination (e.g., converting cytosine basesMoto uracil) (Lindahl and Nyberg, 1972). In addition, reactive mole-
cules, found within the nucleus, can chemically attack DNA,
causing a plethora of DNA adducts and lesions (Lindahl, 1993).
Despite this, the genome is kept free of errors because the cell
has evolved several mechanisms to detect, and then to repair,
damaged DNA. Reactive oxygen species (ROS) are perhaps
the most ubiquitous and well-known molecules that damage
DNA, but endogenous aldehydes are another class of highly
reactive, metabolically derived molecules that could also pose
a threat to the genome (Yu, 1994). The presence of a carbonyl
group makes this class of organic chemicals highly reactive
toward proteins and DNA.
The human genetic illness Fanconi anemia (FA) results from an
inability to deal with certain forms of DNA damage. The accumu-
lation of DNA damage in FA leads to bone marrow failure, devel-
opmental abnormalities, sterility, and a predisposition to develop
cancer. The endogenous factors that cause this phenotype are
the focus of current research, with evidence pointing to two con-
trasting sources. The first comes frommice and humans afflicted
with FA, who simultaneously lack the acetaldehyde-catabolizing
enzymeALDH2 (Garaycoechea et al., 2012;Hira et al., 2013; Lan-
gevin et al., 2011). This combined deficiency greatly accelerates
hematopoietic stemcell (HSC) attrition and theonset of leukemia.
These mice are sensitized to ethanol, indicating that an accumu-
lation of acetaldehyde is sufficient to produceHSC loss. The sec-
ond comes from a very recent study on FA-deficient mice, which
were stimulated to induce stress-driven hematopoiesis (Walter
et al., 2015). This experimental manipulation led to an increase
in HSC cycling, induction of ROS, and an accumulation of oxida-
tive DNA lesions. These two disparate drivers of endogenous
DNA damage are not linked, so it is unclear what exactly the FA
DNA repair pathway responds to in the physiological setting.
Moreover, it raises questions concerning the main cause of
HSC attrition in FA and which endogenous factor causes it.lecular Cell 60, 177–188, October 1, 2015 ª2015 The Authors 177
Figure 1. ADH5 Prevents the Accumulation
of Endogenous FormaldehydeDNAAdducts
(A) Scheme outlining the origin and catabolism of
endogenous formaldehyde by ADH5. MPO, mye-
loperoxidase; ADH, alcohol dehydrogenase.
(B) Upper panel, immunoblot of whole cell extracts
from wild-type (WT) and Adh5/ mouse tissues
probed with affinity-purified rabbit anti-ADH5
antiserum. b-actin was used as loading control.
Lower panel shows an immunoblot of total kidney
extract from wild-type mice loaded as 2-fold dilu-
tion series, comparing the relative expression of
ADH5 with bone marrow.
(C) Formaldehyde reacts with guanine to form the
N2-hydroxymethyl-dG adduct, which can then be
detected and quantified by mass spectrometry
after reduction to N2-methyl-dG.
(D) Bar chart representing the frequency of
N2-methyl-dG per 107 dG bases in genomic
DNA, obtained from bone marrow, kidney, and
liver of WT or Adh5/ mice at 10–15 weeks
or following 4 weeks of methanol exposure. **p <
0.01; *p < 0.05. Data are represented as
mean ± SEM.The body also produces formaldehyde, which is simpler and
much more pernicious than acetaldehyde. Formaldehyde is
highly reactive and readily crosslinks both proteins and nucleic
acids (McGhee and von Hippel, 1977). The propensity of formal-
dehyde to crosslink DNA and proteins has been exploited in or-
der to preserve tissues and study interactions between proteins
and specific DNA sequences. Other environmental sources of
formaldehyde include tobacco smoke, e-cigarettes, the sweet-
ener aspartame, and, most directly, accidental consumption of
methanol (Jensen et al., 2015; Trocho et al., 1998). However,
endogenous formaldehyde is ubiquitous within cells because it
is a by-product of enzymatic oxidative demethylation reactions.
Histone, RNA, and DNA demethylation by the KDM1/JMJC or
ABH family of enzymes produces formaldehyde within the nu-
cleus (Loenarz and Schofield, 2008; Shi et al., 2004; Walport
et al., 2012). Formaldehyde can also be generated by the action
of the neutrophil enzymemyeloperoxidase and by N-demethyla-
tion, a common biochemical process (Figure 1A) (Anderson
et al., 1997).
Therefore, because of its abundance and chemical proper-
ties, formaldehyde could pose a significant risk to the genomic
integrity of living organisms. Very early studies showed the
potent mutagenic consequences of formaldehyde on fly larvae
(Auerbach, 1949; Herskowitz, 1950). Despite this, our under-178 Molecular Cell 60, 177–188, October 1, 2015 ª2015 The Authorsstanding of how cells and organisms
protect themselves against formalde-
hyde is only just starting to emerge. It
was recently discovered that yeast mu-
tants deficient in the protease WSS1
are hypersensitive to formaldehyde
(Stingele et al., 2014). This protease
acts together with translesion synthesis
to prevent genomic instability caused
by formaldehyde-induced protein-DNAcrosslinks. Although WSS1 orthologs exist in higher organisms,
it remains unclear whether their function in DNA repair is
conserved. On the other hand, vertebrate cells deficient in the
FA DNA crosslink repair pathway have been shown to be exqui-
sitely sensitive to physiological levels of formaldehyde (Ridpath
et al., 2007).
In a manner analogous to acetaldehyde, formaldehyde is
detoxified from the body by alcohol dehydrogenase 5 (ADH5).
This enzyme is highly conserved from vertebrates to bacteria,
and it bio-inactivates formaldehyde by a mechanism unrelated
to that of enzymes from the aldehyde dehydrogenase super-
family, like ALDH2 (Figure 1A) (Sanghani et al., 2000; Staab
et al., 2009). The functional importance of ADH5 was revealed
by our observation that avian DT40 lymphoma B cells lacking
ADH5 in combination with the FA DNA repair pathway are not
viable (Rosado et al., 2011). Here we explain how mammals
protect themselves against the DNA damage caused by endog-
enously produced formaldehyde. Surprisingly, we find that
formaldehyde-induced DNA damage requires repair by the
Fanconi repair pathway in the liver and kidney as well as in
blood stem cells. Failure to repair this damage results in the
loss of homeostasis and dysfunction of all three organs. Finally,
repair of this damage is essential to prevent neoplastic
transformation.
RESULTS
ADH5 Prevents Endogenous Formaldehyde from
Forming DNA Adducts
It is clear that numerous cytoplasmic and nuclear pathways
release formaldehyde, which is detectable in human blood at
significant levels (approximately 29 mM) (Luo et al., 2001). To bet-
ter understand the clearance mechanism of this very reactive
molecule and to determine where ADH5 is expressed in mice,
we raised and affinity-purified a rabbit polyclonal antiserum spe-
cific to mouse ADH5. This antiserum detects a 39-kDa protein
that is expressed in several tissues, with the greatest expression
in the liver and kidney (Figure 1B). Dilution analysis reveals
that the expression of ADH5 in the bone marrow is between
32- and 64-fold lower than in the kidney (Figure 1B).
Endogenous formaldehyde can be produced in proximity to
chromosomes, potentially enabling it to react with DNA. We
wanted to address two questions: first, is sufficient endogenous
formaldehyde produced to adduct DNA in a mammal? Second,
does ADH5 remove this endogenous formaldehyde and thereby
suppress its availability to damage DNA? Formaldehyde
spontaneously and efficiently reacts with guanine to yield N2-hy-
droxymethyl-deoxyguanine (N2-hydroxymethyl-dG) (Figure 1C).
Although the mutagenic consequences of this adduct have not
yet been determined, it is reasonably stable in DNA (Yu et al.,
2015). This modification provides a biomarker for the prevalence
of formaldehyde-modified DNA. We quantified the levels of the
reduced form of N2-hydroxymethyl-dG in mouse tissues using
ultrasensitive nano ultra-performance liquid chromatography-
tandemmass spectrometry (nano-LC-MS/MS). There was a sig-
nificant increase of N2-methyl-dG in the bone marrow (1.7-fold),
kidney (1.7-fold), and liver (2.3-fold) of Adh5/ mice when
compared to wild-type aged-matched controls (Figure 1D).
We went on to expose mice to methanol via their drinking
water for 4 weeks. Methanol is an exogenous source of formal-
dehyde due to its oxidation by catalase and alcohol dehydroge-
nases 1 and 2. This treatment caused a further accumulation
of N2-methyl-dG both in wild-type and, more strikingly, in
Adh5/ mice (Figure 1D). These results show that ADH5 is a
widely expressed enzyme in mice and that it prevents formalde-
hyde, from both endogenous and exogenous sources, from
adducting DNA.
Deficiency of Fancd2 in Adh5–/– Mice Leads to Bone
Marrow Failure
The fact that endogenous formaldehyde can accumulate to such
an extent as to adduct DNA led us to interrogate whether this
necessitated DNA repair. In avian DT40 cells, genetic deficiency
of ADH5 in combination with the FA DNA repair pathway results
in synthetic lethality (Rosado et al., 2011). We therefore set out
to test what happens when we combined deficiency of the key
FA protein FANCD2 with Adh5 disruption in mice. In the first
instance, we interbred mice to obtain Adh5/Fancd2/ ani-
mals on a C57BL/6 background. None were obtained at day
21 postnatally, indicating synthetic lethality (Figure S1A).
Furthermore, the frequency of double-mutant embryos at day
E13.5 was significantly decreased, with the remaining
Adh5/Fancd2/ embryos exhibiting developmental delayMo(Figure S1B). In parallel, we also attempted to breed
Adh5/Fancd2/ mice on a C57BL/6;129S6/Sv hybrid back-
ground. In this case, Adh5/Fancd2/mice were born at a fre-
quency of 7.2% (in contrast to the expected 12.5% Mendelian
ratio, of Adh5/Fancd2+/ 3 Adh5+/Fancd2+/ intercrosses)
(Figure S1C). We conducted an additional cross where
Adh5/Fancd2+/ females were bred with Adh5/Fancd2+/
males. Again, this resulted in viable mice, although the observed
ratio was significantly reduced (4.8% versus the expected 25%).
This is in stark contrast to Aldh2/Fancd2/ mice, which
cannot be born from Aldh2/ mothers (Langevin et al., 2011;
Oberbeck et al., 2014).
Viable Adh5/Fancd2/ mice were 32% smaller than wild-
type littermate controls (Figure S1D). In a very short period of
time (3–7 weeks after birth), these mice became subdued and
had to be culled (Figure 2A). These compromised animals
showed blood pancytopenia (Figures 2B and S2A) and greatly
reduced bone marrow cellularity (Figure 2C), and bone marrow
aspirates and histology revealed an almost complete failure of
hematopoiesis (Figure S2B).
An Essential Role for ADH5 and FANCD2 in Blood Stem
Cells
The rapid onset of multilineage cytopenia in Adh5/Fancd2/
mice is indicative of a failure to sustain hematopoiesis. The pro-
duction of blood is hierarchical, where a small population of long-
term HSCs supply a pool of transient amplifying cells, which
ultimately give rise to committed myeloid and lymphoid progen-
itor cells. We therefore quantified the frequency of hematopoietic
stem and progenitor cells (HSPCs; Lineagec-kit+Sca-1+) in
Adh5/Fancd2/ mice by flow cytometry (Figure 2D). This
analysis was performed in 3-week-old mice, before the onset
of peripheral pancytopenia. We found that there was more
than a 100-fold reduction in the frequency of HSPCs in the
bone marrow of double-mutant mice when compared to con-
genic controls (Figure 2D, right panel). More stringent sur-
face markers (HSCs; LinCD41CD48CD150+c-kit+Sca-1+ or
SLAM-LKS) revealed the frequency of long-term HSCs to be
952-fold less than in wild-type bone marrow (Figures 2D and
S2C). To functionally test the HSC pool in vivo, we carried out
the spleen colony-forming unit assay (CFU-S10), which quanti-
fied the frequency of early, multipotent short-term HSCs (Till
and McCulloch, 1961). This showed that Adh5/Fancd2/
bone marrow had an 87-fold reduction in the frequency of
CFU-S10 (Figure 2E).
HSCs not only are multipotent but also have the ability to self-
renew in the long term. To assess the frequency of functional
HSCs, we conducted competitive repopulation experiments.
We transplanted equal numbers of wild-type (competitor) and
mutant (test) bone marrow cells into lethally irradiated recipients
and assessed the contribution of the mutant bone marrow to pe-
ripheral blood production over time. We found that Adh5/ and
Fancd2/ single mutants had 3- and 10-fold defects, respec-
tively, in their ability to contribute to blood production at
16 weeks. However, Adh5/Fancd2/ bone marrow contrib-
uted to less than 0.1% of total blood production, which consti-
tutes a 1,640-fold defect compared to wild-type (Figure 2F).
Strikingly, when a 25-fold excess of Adh5/Fancd2/ tolecular Cell 60, 177–188, October 1, 2015 ª2015 The Authors 179
Figure 2. Combined Genetic Inactivation
of Adh5 and Fancd2 Leads to Rapid Loss
of HSCs
(A) Kaplan-Meier curve of the survival of
Adh5/Fancd2/ mice compared to allelic
controls.
(B) Quantification of red blood cells in peripheral
blood of 4- to 6-week-oldAdh5/Fancd2/mice
and age-matched controls; each point represents
a single mouse. ****p < 0.0001.
(C) Quantification of nucleated bone marrow
cellularity inAdh5/Fancd2/mice and controls.
****p < 0.0001; n = 14 per control group, and n = 22
in Adh5/Fancd2/ group.
(D) Left, representative flow cytometry plots
showing 50,000 lineage cells, used to quantify
the HSPC pool in wild-type, Adh5/, Fancd2/,
and Adh5/Fancd2/ bone marrow (as LKS:
Linc-kit+Sca-1+). Right, HSC frequency was
quantified in the bone marrow of age-matched
mice using LKS markers or in combination
with alternative cell surface markers (SLAM:
CD41CD48CD150+). Bar graphs show the
mean relative to wild-type. n = 4 per group; **p <
0.01; *p < 0.05.
(E) Frequency of CFU-S10 assessed following
injection of 1 3 105 (control mice) or 2 3 106
(Adh5/Fancd2/mice) nucleated bone marrow
cells into irradiated recipients. Each point repre-
sents the number of spleen colonies (CFU-S10) per
recipient. **p < 0.01; n = 10 and 8 per control and
Adh5/Fancd2/ groups, respectively.
(F–G) The long-term competitive repopulation
assay was performed by transplanting 0.2 3 106
(F) or 5 3 106 (G) ‘‘test’’ cells from wild-type,
Adh5/, Fancd2/, or Adh5/Fancd2/ mice
(CD45.2) together with 0.2 3 106 wild-type
competitor cells (CD45.1) into irradiated recipients
(CD45.1/CD45.2). The plots show the test/
competitor chimerism in peripheral white blood
cells over time.
Data are represented as mean ± SEM. See also
Figures S1 and S2.competitor bone marrow was transplanted, only 0.3% of blood
production was derived from the double-knockout cells (Fig-
ure 2G). These data clearly demonstrate that the combined inac-
tivation of Adh5 and Fancd2 results in a profound, synergistic
reduction in the frequency of functional HSCs.
Endogenous DNA Damage Accumulates in
Adh5–/–Fancd2–/– Hematopoietic Cells
The evidence so far reveals a severe HSC defect in
Adh5/Fancd2/ mice. To complete our analysis we also
analyzed more mature progenitors in the double-knockout
mice and allelic controls, before the onset of peripheral
pancytopenia (Figure S3A). This showed that CFC, CFU-PreB,
CFU-GM, and CFU-E are all significantly depleted in the
Adh5/Fancd2/ mice. Next we assessed granulocyte,
erythroid, and B cell maturation in the bone marrow. Our findings
indicate that Adh5/Fancd2/ mice retain the ability to pro-
duce mature hematopoietic cells from all lineages tested (Fig-
ure S3B). Taken together, these data suggest that the reduction180 Molecular Cell 60, 177–188, October 1, 2015 ª2015 The Authorsin the frequency of committed progenitors and peripheral cells is
likely to be due to the severe contraction of the HSC pool.
The overall expression of ADH5 in total bone marrow is very
low (Figure 1B), this could be because very little ADH5 is ex-
pressed throughout the bone marrow or that its expression is
limited to a small subset of cells. We therefore assessed the
expression of ADH5 in various bonemarrow fractions (Figure 3A).
There is a clear enrichment for the expression of ADH5 in
the stem and early progenitor fractions (Linc-kit+, LK:
Linc-kit+Sca-1, and LKS) compared to the lineage committed
Gr-1+, B220+, and TER-119+ fractions. Finally, since hematopoi-
esis is profoundly depleted in Adh5/Fancd2/ mice, we pre-
dicted there should be an accumulation of DNA damage in these
cells. We therefore measured the abundance of phosphorylated
H2A.X (g-H2A.X), a post-translational modification on a histone
that is induced upon DNA damage, in combination with sur-
face markers by flow cytometry (Figures 3B and 3C). There
was a marked induction of g-H2A.X in the HSPC pool in
Adh5/Fancd2/ marrow, indicating an accumulation of DNA
Figure 3. ADH5 and FANCD2 Suppress DNA
Damage in Hematopoietic Cells
(A) Immunoblot showing the expression of ADH5
in different hematopoietic populations isolated
from the bone marrow of 10-week-old wild-type
mice by flow cytometry. The total protein fraction
was isolated from 100,000 cells, and histone H3
was used as loading control.
(B) Flow cytometric analysis of g-H2A.X
induction within the lineage negative (Lin), Linc-
kit+Sca-1 (LK) and Linc-kit+Sca-1+ (LKS) pop-
ulations in the bone marrow obtained from
Adh5/Fancd2/ and control mice. The bar
graph shows the g-H2A.X fluorescence intensity
relative to the wild-type control. n = 4; *p < 0.05.
(C) Flow cytometry detection of g-H2A.X induction
in the LKS population (HSPC).
(D) Metaphase spreads were prepared from LPS-
activated splenic B cells and scored blinded for the
presence of chromosome aberrations (wild-type
n = 85, Adh5/ n = 93, Fancd2/ n = 91, and
Adh5/Fancd2/ n = 95 metaphases). Repre-
sentative images of Adh5/Fancd2/ meta-
phases are shown on the right (with a chromatid
break and a radial structure indicated by black
arrows). Scale bar, 10 mm.
Data are represented as mean ± SEM. See also
Figure S3.damage in this fraction in the bone marrow. Additionally, we
found that in vitro lipopolysaccharides (LPS)-stimulated splenic
B cells obtained from Adh5/Fancd2/mice had higher levels
of spontaneous chromosome breakages; in fact, some of these
were radial figures, which are the hallmark of FA (Figure 3D).
Moreover, we found that murine embryonic fibroblasts derived
from Adh5/Fancd2/ embryos also exhibited an increased
frequency of chromosomal aberrations that could be further
induced upon exposure to exogenous formaldehyde (Fig-
ure S3C). Together, these data reveal that hematopoietic cells
from Adh5/Fancd2/ accumulate DNA damage.
Formaldehyde, Not Nitric Oxide, Is the Main Genotoxin
Removed by ADH5
In addition to clearing formaldehyde, ADH5 also acts on the gas
nitric oxide (NO), which plays a role in signaling (Liu et al., 2004).
The detoxification mechanism is similar to that for formaldehyde:
NO reacts with glutathione (GSH) to yield S-nitrosoglutathione
(GSNO). In fact, ADH5 is sometimes referred to as nitrosogluta-
thione reductase (GSNOR). It is therefore possible that the ef-
fects we have reported could be due to the clearance of NO
rather than formaldehyde or a combination of both. NO is pro-
duced in cells from the action of nitric oxide synthetase (NOS)
on arginine (Andrew and Mayer, 1999). There are three NOS en-
zymes: neurone specific (nNOS), endothelial (eNOS), and induc-
ible (iNOS/Nos2). iNOS is the main enzyme responsible for the
production of NO in vivo (Mattila and Thomas, 2014). To
test whether NO production by iNOS contributed to the pheno-
type of Adh5/Fancd2/ mice, we attempted to generateMoiNOS/Adh5/Fancd2/ triple-deficient mice on a C57BL/6
background. However, no viable iNOS/Adh5/Fancd2/
mice were born (Figures S4A and S4B). Additionally, the
frequency of iNOS/Adh5/Fancd2/ embryos at E13.5
was not significantly different from the frequency of
Adh5/Fancd2/ embryos, again suggesting that iNOS
disruption could not prevent the embryonic lethality of
Adh5/Fancd2/ mice on a C57BL/6 background. An addi-
tional genetic test was also performed to determine whether
iNOS deficiency improved the 4.8- and 3.6-fold defect in the
frequency of HSPCs (LKS) and HSCs (SLAM-LKS) in Fancd2/
mice (Figure S4C). Again, iNOS/Fancd2/ mice showed
no reduction of both these cell populations compared to
Fancd2/ mice. In summary, these genetic experiments sug-
gest that NO accumulation is not responsible for the extreme
phenotypes that we report in Adh5/Fancd2/ mice. More-
over, reducing NO synthesis does not improve the HSC pool in
Fancd2/ mice.
Next, we asked whether hematopoietic cells (CFU-E and LPS-
blasted splenic B cells) from Adh5/Fancd2/mice were sen-
sitive to either formaldehyde or two distinct types of NO donors
(S-nitrosoglutathione, GSNO; and diethylenetriamine nitric ox-
ide, DETA-NO) (Figures 4A, 4B, S4D, and S4E). Following treat-
ment with formaldehyde, both CFU-E and LPS-activated B cells
obtained fromAdh5/Fancd2/miceweremore sensitive than
single-mutant controls. In contrast, the effect of both GSNO and
DETA-NO exposure resulted in no additive sensitivity in
Adh5/Fancd2/B cells when compared to the allelic controls
(Figure S4D). Interestingly, the Fancd2/ single-mutant CFU-Elecular Cell 60, 177–188, October 1, 2015 ª2015 The Authors 181
Figure 4. Formaldehyde Drives HSCs Attri-
tion in Adh5–/–Fancd2–/– Mice
(A) Graph showing the survival of splenic B
cells following exposure to formaldehyde. B cells
were activated with LPS and were grown in the
presence of formaldehyde for 6 days, and the
viable cell number was assessed by trypan blue
exclusion.
(B) Plot showing the sensitivity of erythroid colony-
forming units (CFU-E) to formaldehyde. Bone
marrow-derived cells (2 3 106) were exposed for
2 hr to varying doses of formaldehyde and plated
onto methylcellulose medium.
In both (A) and (B), the survival was made relative
to the untreated sample. The mean of three inde-
pendent experiments is shown, each carried out in
duplicate. *p < 0.05; **p < 0.01.
(C) Top, scheme outlining the protocol used to
assess the toxicity of methanol to HSCs. Six-
week-old mice were fed with methanol 15% v/v in
the water supply, and HSC frequency was quan-
tified after 4 weeks. Bottom, the graph shows the
flow cytometric quantification of HSCs (SLAM-
LKS markers) for Adh5+/Fancd2/ and control
mice. The bar chart represents the HSC frequency
relative to untreated wild-type animals (n = 4 per
group; **p < 0.01).
(D) Representative flow cytometry plots of LKS
and SLAM-LKS in whole bone marrow of Adh5+/
Fancd2/ mice exposed to water or methanol.
Data are represented as mean ± SEM. See also
Figures S4 and S5.were hypersensitive to DETA-NO compared to controls (Fig-
ure S4E). However, it is important to note that Adh5 deficiency
does not impact on this further, and second the dose of DETA-
NO is very high (0.6–1.2 mM)—this is predicted to release NO
at 16-fold higher levels than those detected under physiological
conditions, whereas the concentration of formaldehyde is com-
parable to that found in serum (Luo et al., 2001; Miller and Meg-
son, 2007).
Subsequently, we wanted to test whether the joint disruption
of Adh5 and Fancd2 sensitized animals to formaldehyde in vivo.
In the first instance, we asked whether maternal exposure
to methanol damaged Adh5/Fancd2/ embryos. It is well
known that this alcohol is a potent teratogen (Rogers et al.,
2004). Timed matings were set up, and females were exposed
to methanol or saline intraperitoneally during the first trimester
of pregnancy (E7.5). At day E16.5, pregnant females were sacri-
ficed and embryos examined and genotyped (Figure S5A). The
frequency of Adh5/Fancd2/ embryos was reduced in meth-
anol-exposed mothers compared to the saline control (2.4%
versus 9.2%) (Figure S5B). The two Adh5/Fancd2/ embryos
that survived methanol exposure carried developmental defects
(Figure S5C). We finally tested whether an exogenous source of
formaldehyde could directly impact on HSCs.We did not expose
Adh5/Fancd2/ mice to methanol since these animals were
already so severely compromised, with themajority dying before
6 weeks of age. Instead, Adh5+/Fancd2/ mice were used,
because we suspected haploinsufficiency in the case of
Adh5+/ mice. We therefore exposed 6-week-old mice to 15%
methanol in their water supply for 4 weeks, before assessing182 Molecular Cell 60, 177–188, October 1, 2015 ª2015 The Authorsthe frequency of HSCs by flow cytometry (Figure 4C). Following
exposure to methanol, there was a mild 2.3-fold reduction in the
frequency of HSCs in Fancd2/ mice. However, there was a
marked, 15.5-fold reduction in the frequency of Adh5+/
Fancd2/ HSCs (Figures 4C and 4D). Taken together, these
data show that there is a synergistic requirement for ADH5
and FANCD2 to protect cells from the genotoxic effects of
formaldehyde.
Formaldehyde Causes Karyomegalic Degeneration and
Compromises Nephrons
A striking feature of Adh5/Fancd2/ mice is that they are
significantly smaller than littermate controls (Figure S1D). This
suggested to us that formaldehyde causes damage beyond he-
matopoiesis. In fact, histological examination revealed that many
organs contained cells with atypically large nuclei (karyomegaly)
(Figures 5A, S6A, S6B, and S6C). Karyomegaly was most
marked in the liver, with a significant proportion of hepatocytes
containing 8n and 16n nuclei, indicating that the cells have un-
dergone replication cycles without cell division (Figures 5B and
S6E). There was activation of the DNA damage response in the
liver with the induction of p53 and g-H2A.X (Figures 5C, 5D,
and S6D).
In addition to liver abnormalities, most Adh5/Fancd2/
mice developed renal dysfunction. These mice exhibited uremia
within 4–6 weeks, which correlated with the excretion of albu-
min in the urine (Figures 5E and 5F). Albuminuria reflects glomer-
ular injury, and this was corroborated by histological analysis,
which revealed a reduced glomerular size in Adh5/Fancd2/
Figure 5. DNADamage Causes Liver Karyo-
megaly and Kidney Dysfunction in Adh5–/–-
Fancd2–/– Mice
(A) H&E stain of liver sections from wild-type and
Adh5/Fancd2/ mice showing the central vein
(4003). Scale bar represents 50 mm.
(B) Quantification of hepatocyte nuclear DNA
content (n = 3 mice per group; *p < 0.05; **p <
0.01).
(C) Immunohistochemistry of liver sections from
age-matched wild-type and Adh5/Fancd2/
mice showing the presence of g-H2A.X. Scale bar
represents 50 mm.
(D) Immunoblots for p53, g-H2A.X, and histone H3
in nuclear extracts obtained from 4-week-old
Adh5/Fancd2/ mice and littermate controls.
(E) Serum urea concentration in 5- to 6-week-old
mice and congenic controls. Each point repre-
sents a single mouse (data are represented as
mean ± SEM; ***p < 0.001).
(F) Urine (5 ml) obtained from individual mice
was resolved by SDS-PAGE and stained with
Coomassie blue. The urine obtained from
Adh5/Fancd2/ mice contains large amounts
of a 60-kDa protein (*, albumin).
(G) Quantification of DNA content in kidney nuclei.
Bar chart shows the percentage of nuclei that
contain 2n or 4n DNA (n = 3 per group; **p < 0.01).
(H) Panels show EM images of Adh5/Fancd2/
animals and allelic controls, showing effacement
of the foot processes in 6-week-old
Adh5/Fancd2/ mice (RBC, red blood cell;
GBM, glomerular basement membrane; FP, po-
docyte foot processes; and U, urinary space).
Scale bar represents 2 mm.
See also Figure S6.mice (Figures S6F and S6G). We also noticed that the tubular
epithelial cells displayed varying degrees of karyomegaly, with
an accumulation of cells at the G2/M (4n) stage of the cell cycle
(Figures 5G and S6F). Finally, we looked at the glomeruli of
Adh5/Fancd2/mice in more detail to determine which cells
were being damaged. Electron microscopy of this structure re-
vealed that the glomeruli of very young Adh5/Fancd2/
mice were largely normal, but those obtained from older, uremic
animals were severely damaged (Figure 5H). The podocytes (a
key cell type that forms the interface between the blood and
the urinary space) showed degenerative changes with efface-
ment of the foot processes. When put together, these data
show that lack of protection against endogenous formaldehyde
leads to widespread DNA damage, causing twomajor metabolic
organs to dysfunction—the liver and the kidney.
Hematopoietic Rescue Preserves Nephron Function
The data so far suggest that endogenous formaldehyde has
widespread genotoxic consequences. However, it was not clear
to us whether the hematopoietic and systemic effects were
distinct or linked. Bone marrow transplantation (BMT) of wild-Motype bone marrow into young Adh5/Fancd2/ mice would
allow us to test this, by rescuing the hematopoietic aspect of
the phenotype. We reasoned that this could extend the lifespan
of transplanted mice, allowing us to ask whether additional as-
pects of the phenotype are revealed.
We therefore performed BMT with wild-type marrow into 3- to
4-week-old Adh5/Fancd2/ mice (Figure 6A). A significant
proportion (6/33) of Adh5/Fancd2/ transplanted mice
showed multi-lineage reconstitution and survived well beyond
3–7 weeks (Figure 6B). On the surface, the frequency of reconsti-
tution appears low, but one has to consider that BMT was
performed without any conditioning. Conditioning protocols
generally involve exposing mice to chemotherapy or radia-
tion—both damage DNA andwould inevitably confound our sub-
sequent analysis.
At regular intervals after the transplant, blood samples were
taken to assess hematopoietic, liver, and kidney function. All
transplanted mice showed a progressive increase in the serum
level of the liver enzyme aspartate transaminase (AST), which
is indicative of a decline in liver function (Figure 6C). In contrast,
and completely unexpectedly, not a single transplantedlecular Cell 60, 177–188, October 1, 2015 ª2015 The Authors 183
Figure 6. Consequences of Bone Marrow
Transplantation in Adh5–/–Fancd2–/– Mice
(A) Scheme outlining the protocol for the trans-
plantation of wild-type bone marrow into
Adh5/Fancd2/ mice and their subsequent
analysis.
(B) Kaplan-Meier survival graph of non-trans-
planted and transplanted Adh5/Fancd2/
mice. Blue/red squares denote mice developing
T-cell leukemia and liver dysplasia, while the
red square represents a mouse that developed
both hepatocellular carcinoma (HCC) and chol-
angiocarcinoma (CC). p < 0.0001 Log-Rank
(Mantel-Cox test).
(C) Serum aspartate transaminase (AST) levels as
an indicator of liver function in the cohort of non-
transplanted (inverted triangles) and transplanted
Adh5/Fancd2/ mice (squares).
(D) Serum urea concentrations as an indicator of
kidney function in the cohort of non-transplanted
and transplanted Adh5/Fancd2/ mice. Data
are represented as mean ± SEM.
(E) Left panels show EM images of 6-week-old
and transplanted 28-week-old Adh5/Fancd2/
mice (BMT, bone marrow transplant; GBM,
glomerular basement membrane; FP, podocyte
foot processes; and U, urinary space). Scale bar
represents 2 mm. Right panel is a bar chart
showing the quantification of foot process width
(FPW, mm) from EM pictures.
(F) Percentage of nuclei with two or more g-H2A.X
foci in kidney sections (*p < 0.05).
(G) Table showing the immunophenotype of
the leukemic blasts in transplanted Adh5/
Fancd2/ mice.
(H) Left panel, H&E staining of a liver section
(4003) from the mouse showing both HCC and
CC. N denotes normal hepatocytes. Right panels
show H&E staining of liver sections (4003) from
mice that developed leukemia but with abnormal
hepatic histology (BDD, bile duct dysplasia; HD,
hepatocyte dysplasia; L, leukemia; and N, normal
liver).
See also Figure S7.Adh5/Fancd2/ mouse developed kidney failure or signifi-
cant proteinuria (Figures 6D and S7A). Non-transplanted mice
developed kidney dysfunction, associated with increased pro-
tein in the urine due to severely damaged glomeruli. From elec-
tron microscopy (EM) images of glomeruli, we measured the
foot process width (FPW), which is an indicator of the structural
integrity of the filtration unit. The FPWwas increased in glomeruli
of untransplanted Adh5/Fancd2/mice. We therefore exam-
ined the glomeruli of the transplanted mice by EM and noted a
marked attenuation of podocyte damage (Figure 6E).
Finally, we asked whether BMT protected the kidney from
failing because it reduced the level of DNA damage. In the first
instance, we determined the amount of formaldehyde DNA ad-
ducts in the kidney and liver of transplanted Adh5/Fancd2/
mice. It is important to reiterate that this base adduct serves as184 Molecular Cell 60, 177–188, October 1, 2015 ª2015 The Authorsbiomarker for DNA modification by endogenous formaldehyde.
We assessed the level of this biomarker adduct in livers and kid-
neys of Adh5/ mice as controls at 3–6 weeks and more than
16 weeks old (Figure S7B). The levels of N2-methyl-dG showed
an increase in the livers of both Adh5/ and transplanted
Adh5/Fancd2/mice compared to 3- to 6-week-old controls.
In contrast, the level of adducts in the kidney showed that
the transplanted Adh5/Fancd2/ stopped accumulating N2-
methyl-dG, indicating that bonemarrow transplantation reduced
the exposure of the kidneys to formaldehyde. Furthermore, when
we scored the number of nuclei in the nephrons with g-H2A.X
foci, we noted a marked suppression following BMT in
Adh5/Fancd2/ mice (Figures 6F and S7C). Therefore the
reduction of DNA adducts positively correlates with a reduction
in DNA damage. These results indicate that restoration of
Figure 7. Model for Genetic Protection against Endogenous Formal-
dehyde and Human Disease
(A) In HSCs, two non-overlapping aldehyde catabolism systems operate to
remove longer chained aldehydes (ALDH2) and formaldehyde (ADH5).
Disruption of ADH5 hasmore drastic consequences on HSC function, possibly
because the burden of formaldehyde is greater in HSCs compared to other
aldehydes or because the former is more toxic.
(B) Model integrating the DNA repair proteins that are known and that might
protect against endogenous formaldehyde. Human genetic deficiency in DNA
crosslink repair causes damage to three main organs. In FA, only the bone
marrow is affected, in KIN only the kidney is affected, and in xeroderma pig-
mentosum/Cockayne syndrome (XPCS; variant Cockayne syndrome) all three
organs are affected. Taking away ADH5 in FA-repair-defective mice results in
damage in all organs such as what is seen in XPCS.hematopoiesis extended the lifespan ofAdh5/Fancd2/mice
and remarkably protected kidney function, suggesting a sys-
temic role for the blood circulation in removing formaldehyde.
However, non-cell autonomous formaldehyde catabolism does
not provide protection for hepatocytes and is also not sufficient
to suppress neoplastic transformation.
All transplanted mice eventually died of neoplasia, with five
mice developing acute T-lymphoblastic leukemia (T-ALL) (Fig-
ures 6B and 6G). In all cases, the ALL was derived from the
Adh5/Fancd2/ recipient (Figure S7D). The ALL was alwaysMoof a T-cell origin, but some were derived from more mature
(CD4 or CD8 single positive) cells, while others were derived
from less mature T-cell progenitors (CD4CD8 double positive).
This suggests that the combined action of ADH5 and FANCD2
is important not only for the survival of HSCs but also to prevent
neoplastic transformation of hematopoietic cells.
Additionally, one mouse developed two simultaneous liver-
derived cancers (hepatocellular carcinoma and cholangiocarci-
noma) (Figure 6H, left panel). This prompted us to examine the
livers of the transplanted mice that succumbed to leukemia.
On all occasions, the liver histology was abnormal with multiple
areas of hepatic and bile duct dysplasia throughout the organ
(Figure 6H, right panels). Such lesions are well-recognized pre-
malignant changes (Libbrecht et al., 2005). This suggests that
ADH5 and FANCD2 also play an important role in suppressing
carcinogenesis in at least one epithelial organ.
DISCUSSION
Endogenous formaldehyde is produced in mammals at suffi-
cient levels to cause lethal damage. Two processes prevent
this reactive metabolite from causing lasting genetic damage
to HSCs, hepatocytes, and nephrons. The most immediate
protection is by ADH5, which detoxifies formaldehyde. An
essential backup is provided by the FA DNA crosslink repair
pathway, which is deficient in the human illness FA. While pro-
tection against formaldehyde operates within HSCs and hepa-
tocytes, the hematopoietic compartment may also be important
in providing nephrons with systemic protection against this
aldehyde.
An inescapable conclusion of this work is that the body must
produce sufficient amounts of reactive formaldehyde that can
cause lasting damage. Endogenous formaldehyde is produced
by oxidative demethylating enzymes. Formaldehyde can also
come from exogenous routes, like tobacco smoke, e-cigarettes,
the sweetener aspartame, and most directly from the consump-
tion of methanol (Jensen et al., 2015; Trocho et al., 1998).
Whereas large doses ofmethanol are very toxic in humans, mod-
erate levels are present in many foods, andmethanol can also be
produced by certain species of commensal bacteria (Dorokhov
et al., 2015). In the future, it will be important to define how
much of the cellular formaldehyde burden comes from exoge-
nous and endogenous sources. Modulating such sources may
provide a means to limit toxicity caused by this molecule in FA
patients.
Aldehydes broken down by ALDH2 are clearly important
endogenous DNA-damaging agents in HSCs (Garaycoechea
et al., 2012). However, this work shows that ALDH2 cannot
compensate for ADH5 in HSCs (Figure 7A). Themore rapid onset
of bone marrow failure in Adh5/Fancd2/ compared to
Aldh2/Fancd2/mice, in addition to the involvement of addi-
tional tissues, suggests that the compound(s) detoxified by
ADH5 are much more potent or abundant genotoxins than those
cleared by ALDH2 (Figures 7A, S7E, and S7F). The properties of
the two aldehyde catabolism systems exhibit another key differ-
ence: maternal ALDH2 expression is crucial to protect the em-
bryo against DNA damage (Oberbeck et al., 2014), whereas
this does not appear to be the case with ADH5.lecular Cell 60, 177–188, October 1, 2015 ª2015 The Authors 185
In addition to formaldehyde, ADH5 also bio-inactivates NO,
which can damage DNA (Nguyen et al., 1992). Adh5/ mice
are susceptible to developing liver cancer following exposure
to the carcinogen diethylnitrosamine because of nitrosylation
and inactivation of the DNA repair enzyme O6-alkylguanine-
DNA alkyltransferase (AGT) (Wei et al., 2010). However, we
show through both in vivo and in vitro studies that formaldehyde
rather than NO is likely to drive the endogenous genotoxicity in
Adh5/Fancd2/ mice. A particularly worrying therapeutic
avenue is the development of ADH5 antagonists as a potential
drug to treat inflammatory diseases (Blonder et al., 2014), due
to the prediction that such drugs would enable NO to accumu-
late. Our work suggests that although ADH5 inhibition may well
provide anti-inflammatory activity, it would also cause endoge-
nous formaldehyde to accumulate and damage DNA.
Recent work suggests that the loss of HSCs in human FA pa-
tients might be a consequence of stress-induced hematopoie-
sis, which causes the release of ROS (Walter et al., 2015). In
contrast, the work here shows that accumulation of DNA dam-
age caused by endogenous formaldehyde is a much more
potent and substantive driver of the HSC attrition in the context
of FA repair deficiency. Thework presented herein provides even
stronger support for the view that endogenous aldehydes rather
than ROS are themost likely driver of HSC attrition in FA patients.
Liver and kidney degeneration are not features of FA, but they
are features of other DNA-crosslink-repair-deficient syndromes
in humans. Humans and mice lacking the XPF-ERCC1 nuclease
complex develop HSC attrition and liver and kidney failure
(Bogliolo et al., 2013; Kashiyama et al., 2013; Niedernhofer
et al., 2006). In addition, humans lacking the FAN1 nuclease
develop chronic kidney failure with features similar to the
Adh5/Fancd2/ mice that we report here (Zhou et al.,
2012). Thus, Adh5 deficiency may result in the accumulation of
sufficient endogenous formaldehyde to necessitate all three
repair processes—the FA pathway, XPF-ERCC1, and FAN1 (Fig-
ure 7B). If indeed true, then attenuating the production of endog-
enous formaldehyde may be of therapeutic value in all three in-
stances. We show here that endogenous formaldehyde directly
adducts DNA. It is also well established that formaldehyde-
damaged DNA can cause chromosome damage and is muta-
genic. We do not know the precise chemical nature of the types
of DNA lesions necessitating repair by the FA pathway, but DNA-
protein and DNA-DNA crosslinks are very strong candidates
(Knipscheer et al., 2009). Understanding how exactly the FA,
XPF-ERCC1, FAN1, or the recently identified WSS1 proteins
resolve such damage is an important future challenge. Further-
more, the relationship between these various repair proteins
and their possible interdependence needs to be defined further.
The role for formaldehyde in human carcinogenesis is contro-
versial. Although some evidence links environmental and occu-
pational formaldehyde exposure to certain cancers, much of
this evidence is weak. Rodents exposed to high concentrations
of formaldehyde vapor develop upper airway cancers, indicating
it is a carcinogen in this context (Swenberg et al., 2013). However,
it is very clear from our work that sufficient formaldehyde is pro-
duced within the body to cause widespread DNA damage. Over
time, this damage promotes malignant transformation. This
observation therefore provides proof that endogenous formalde-186 Molecular Cell 60, 177–188, October 1, 2015 ª2015 The Authorshyde is a carcinogen in mammals. In the future, identifying the
sources and defining the chemical nature of DNA damage
caused by formaldehyde may have important general implica-
tions for cancer predisposition and the aging process in humans.
EXPERIMENTAL PROCEDURES
For detailed experimental procedures refer to the accompanying Supple-
mental Experimental Procedures.
Mouse Genetics and Method Summary
All animal work was undertaken with the approval of the UK Home Office
(License 70/7657). Mice were maintained under specific pathogen-free condi-
tions. Fancd2/ mice (Fancd2tm1Hou, MGI code: 2673422, 129S4/SvJae)
were a gift from M. Grompe (Houghtaling et al., 2003). Adh5/ (also known
as Gsnor/) and iNOS/ mice (C57BL/6) were obtained from Dr. L. Liu at
UCSF (Liu et al., 2004). Competitive repopulation experiment and CFU-S
were performed essentially as described previously (Kiel et al., 2005; Till and
McCulloch, 1961). Flow cytometry was also performed as described previ-
ously (Garaycoechea et al., 2012).
Formaldehyde-Induced DNA Mono-Adducts Detection
DNA was isolated using a NucleoBond DNA isolation kit, with small modifica-
tions. DNA was then reduced and digested as described previously (Yu et al.,
2015). Following digestion, hydrolyzed DNA was filtered and injected onto an
Agilent 1200 HPLC fraction collection system equipped with a diode-array de-
tector. dG and N2-methyl-dG were separated and eluted. The amounts of dG
were quantified according to the UV peak area with a calibration curve. The
amounts of N2-methyl-dG were detected and quantified with a calibration
curve on an AB SCIEX Triple Quad 6500 mass spectrometer interfaced with
an Eksigent nanoLC Ultra 2D system. N2-hydroxymethyl-dG was quantified
as N2-methyl-dG after reduction. The internal standard [13C10
15N5]-N2-Me-
dG was synthesized by the Swenberg lab. Chemicals were from Sigma.
Methanol Exposure Experiments
A mixture of methanol, blackcurrant juice, and water (15:10:75) was given to
6-week-old mice as the only source of fluid. In control animals, methanol
was omitted. After 4 weeks, mice were culled and bone marrow isolated for
analysis by flow cytometry to determine frequency of HSCs, progenitor pools,
and induction of g-H2A.X.
Statistical Analysis
Unless otherwise stated, data reflect the mean ± SEM, and an unpaired
two-tailed Student’s t test was used to assess the statistical significance. Con-
tingency analysis was done using Fisher’s exact test with 95% confidence
interval.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.molcel.2015.08.020.
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